Skip to content

Drug interactions

Eslicarbazepine + Glimepiride-pioglitazone

Severity: Minor

Eslicarbazepine and Glimepiride-pioglitazone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine is a weak-to-moderate CYP3A4 inducer and may slightly reduce pioglitazone exposure. A meaningful loss of glycemic control is unlikely but possible.

What this interaction means in plain words

Eslicarbazepine and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eslicarbazepine belongs to Central Nervous System; Glimepiride-pioglitazone belongs to Endocrine.

Evidence level: Low

Why it happens

Induction of CYP3A4 by eslicarbazepine increasing pioglitazone clearance.

What to do

Monitor glucose control when eslicarbazepine is started or stopped and titrate pioglitazone if needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Glimepiride-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eslicarbazepine with Glimepiride-pioglitazone?

MediHelp rates the interaction as minor. Eslicarbazepine and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eslicarbazepine is a weak-to-moderate CYP3A4 inducer and may slightly reduce pioglitazone exposure. A meaningful loss of glycemic control is unlikely but possible.

How serious is the interaction between Eslicarbazepine and Glimepiride-pioglitazone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose control when eslicarbazepine is started or stopped and titrate pioglitazone if needed.

What other medicines interact with Glimepiride-pioglitazone?

MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in